New generation of fully recombinant, protease-activated monoclonal antibodies that can achieve unprecedented levels of tissue-specific targeting.
There’s no risk. Start your trial today to see profiles of CytomX Therapeutics plus 5594 other startups.
Start Free 7 Day Trial Now